This company listing is no longer active
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
DSM-Firmenich 過去の業績
過去 基準チェック /16
DSM-Firmenich's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 20.5% annually. Revenues have been declining at an average rate of 0.8% per year. DSM-Firmenich's return on equity is 4.4%, and it has net margins of 5.4%.
主要情報
-20.7%
収益成長率
-20.2%
EPS成長率
Chemicals 業界の成長 | 13.1% |
収益成長率 | -0.8% |
株主資本利益率 | 4.4% |
ネット・マージン | 5.4% |
次回の業績アップデート | 02 Aug 2023 |
最近の業績更新
Recent updates
収支内訳
DSM-Firmenich の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Dec 22 | 8,390 | 454 | 1,772 | 295 |
30 Sep 22 | 9,582 | 837 | 895 | 162 |
30 Jun 22 | 9,802 | 1,082 | 1,789 | 323 |
31 Mar 22 | 9,503 | 1,081 | 1,789 | 323 |
31 Dec 21 | 7,269 | 820 | 1,649 | 274 |
30 Sep 21 | 7,955 | 660 | 2,517 | 560 |
30 Jun 21 | 7,558 | 493 | 1,622 | 398 |
31 Mar 21 | 7,572 | 423 | 1,622 | 398 |
31 Dec 20 | 8,106 | 448 | 1,622 | 398 |
30 Sep 20 | 7,960 | 510 | 1,639 | 295 |
30 Jun 20 | 8,034 | 557 | 1,639 | 295 |
31 Mar 20 | 9,011 | 722 | 1,795 | 349 |
31 Dec 19 | 7,998 | 675 | 1,639 | 295 |
30 Sep 19 | 8,272 | 820 | 1,839 | 348 |
30 Jun 19 | 8,502 | 794 | 1,839 | 348 |
31 Mar 19 | 9,124 | 934 | 1,839 | 348 |
31 Dec 18 | 9,267 | 1,069 | 1,839 | 348 |
30 Sep 18 | 9,235 | 984 | 1,753 | 334 |
30 Jun 18 | 9,106 | 2,082 | 1,753 | 334 |
31 Mar 18 | 8,908 | 1,942 | 1,753 | 334 |
31 Dec 17 | 8,632 | 1,761 | 1,753 | 334 |
30 Sep 17 | 8,471 | 1,676 | 1,694 | 309 |
30 Jun 17 | 8,333 | 738 | 1,694 | 309 |
31 Mar 17 | 8,166 | 711 | 1,694 | 309 |
31 Dec 16 | 7,920 | 645 | 1,694 | 309 |
30 Sep 16 | 7,831 | 588 | 1,605 | 332 |
30 Jun 16 | 7,778 | 274 | 1,605 | 332 |
31 Mar 16 | 7,749 | 214 | 1,605 | 332 |
31 Dec 15 | 7,722 | 174 | 1,605 | 332 |
30 Sep 15 | 7,607 | 66 | 1,382 | 304 |
30 Jun 15 | 7,456 | 114 | 1,382 | 304 |
31 Mar 15 | 7,245 | 115 | 1,382 | 304 |
31 Dec 14 | 7,051 | 123 | 1,382 | 304 |
30 Sep 14 | 7,415 | 112 | 1,430 | 340 |
30 Jun 14 | 7,834 | 138 | 1,430 | 340 |
31 Mar 14 | 8,362 | 182 | 1,430 | 340 |
31 Dec 13 | 8,858 | 252 | 1,430 | 340 |
30 Sep 13 | 8,409 | 363 | 1,396 | 372 |
30 Jun 13 | 8,500 | 335 | 1,396 | 372 |
31 Mar 13 | 8,486 | 257 | 1,396 | 372 |
31 Dec 12 | 8,588 | 280 | 1,396 | 372 |
30 Sep 12 | 9,089 | 453 | 1,356 | 378 |
30 Jun 12 | 9,107 | 543 | 1,356 | 378 |
質の高い収益: DSM N has high quality earnings.
利益率の向上: DSM N's current net profit margins (5.4%) are lower than last year (11.3%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: DSM N's earnings have declined by 20.7% per year over the past 5 years.
成長の加速: DSM N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
収益対業界: DSM N had negative earnings growth (-44.6%) over the past year, making it difficult to compare to the Chemicals industry average (-12.7%).
株主資本利益率
高いROE: DSM N's Return on Equity (4.4%) is considered low.